{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T23:17:15Z","timestamp":1793575035060,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004089","name":"Krembil Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004089","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.semarthrit.2025.152639","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T22:19:48Z","timestamp":1738275588000},"page":"152639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Comparative analysis of disease outcomes: Early vs. late transition from psoriasis to psoriatic arthritis"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3540-0341","authenticated-orcid":false,"given":"Fadi","family":"Kharouf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankti","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangyi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna D","family":"Gladman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semarthrit.2025.152639_bib0001","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","article-title":"Psoriatic arthritis","volume":"7","author":"FitzGerald","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"10.1016\/j.semarthrit.2025.152639_bib0002","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/rheumatology\/kex323","article-title":"Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort","volume":"56","author":"Tillett","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152639_bib0003","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1468-3083.2009.03463.x","article-title":"The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics","volume":"24","author":"Christophers","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152639_bib0004","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152639_bib0005","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/art.33415","article-title":"HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype","volume":"64","author":"Winchester","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152639_bib0006","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/ard.2011.155044","article-title":"Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis","volume":"71","author":"Eder","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152639_bib0007","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1186\/ar2097","article-title":"HLA-C locus alleles may modulate the clinical expression of psoriatic arthritis","volume":"8","author":"Queiro","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152639_bib0008","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/annrheumdis-2014-205461","article-title":"Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype","volume":"75","author":"Haroon","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152639_bib0009","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/rheumatology\/kev296","article-title":"HLA-B27 and psoriatic disease: a modern view of an old relationship","volume":"55","author":"Queiro","year":"2016","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152639_bib0010","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3899\/jrheum.091059","article-title":"Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis","volume":"37","author":"Chandran","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152639_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2021.12.013","article-title":"Time to transition from psoriasis to psoriatic arthritis: a population-based study","volume":"52","author":"Karmacharya","year":"2022","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152639_bib0012","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5114\/reum.2022.120752","article-title":"The role of HLA-Cw6 in psoriasis and psoriatic arthritis","volume":"60","author":"Owczarek","year":"2022","journal-title":"Reumatologia"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152639_bib0013","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/rheumatology\/37.7.760","article-title":"Radiological assessment in psoriatic arthritis","volume":"37","author":"Rahman","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152639_bib0014","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis","volume":"27","author":"Linden","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152639_bib0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/keq262","article-title":"Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program","volume":"50","author":"Gladman","year":"2011","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152639_bib0016","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/annrheumdis-2015-207507","article-title":"Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score","volume":"75","author":"Schoels","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152639_bib0017","first-page":"886","article-title":"Measuring health status in psoriatic arthritis: the health assessment questionnaire and its modification","volume":"22","author":"Blackmore","year":"1995","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152639_bib0018","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/annrheumdis-2021-219961","article-title":"Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis","volume":"81","author":"Gisondi","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2025.152639_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2021.12.013","article-title":"Time to transition from psoriasis to psoriatic arthritis: a population-based study","volume":"52","author":"Karmacharya","year":"2022","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152639_bib0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/annrheumdis-2021-220865","article-title":"Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis","volume":"81","author":"Acosta Felquer","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152639_bib0021","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S2665-9913(23)00034-6","article-title":"Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study","volume":"5","author":"Singla","year":"2023","journal-title":"Lancet Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152639_bib0022","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","article-title":"Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition","volume":"15","author":"Scher","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2025.152639_bib0023","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/acr2.11703","article-title":"What clinical factors affect length of transition to psoriatic arthritis in patients with psoriasis?","volume":"6","author":"Cheemalavagu","year":"2024","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.semarthrit.2025.152639_bib0024","series-title":"ACR Meeting Abstracts","article-title":"Delay between the onset of psoriasis and arthritis in PsA patients from the PsART international cohort [Internet]","year":"2024"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152639_bib0025","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1136\/annrheumdis-2011-201273","article-title":"Obesity and risk of incident psoriatic arthritis in US women","volume":"71","author":"Li","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.semarthrit.2025.152639_bib0026","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/annrheumdis-2012-201299","article-title":"Obesity and the risk of psoriatic arthritis: a population-based study","volume":"71","author":"Love","year":"2012","journal-title":"Ann Rheum Dis [Internet]"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152639_bib0027","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/annrheumdis-2013-204448","article-title":"Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis","volume":"74","author":"Eder","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"6696","key":"10.1016\/j.semarthrit.2025.152639_bib0028","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/29795","article-title":"Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression","volume":"394","author":"Lord","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2025.152639_bib0029","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3389\/fimmu.2014.00368","article-title":"Relationships between adipose tissue and psoriasis, with or without arthritis","volume":"5","author":"Toussirot","year":"2014","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152639_bib0030","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1038\/s41467-018-06933-4","article-title":"Mechanical strain determines the site-specific localization of inflammation and tissue damage in arthritis","volume":"9","author":"Cambr\u00e9","year":"2018","journal-title":"Nat Commun [Internet]"},{"issue":"10","key":"10.1016\/j.semarthrit.2025.152639_bib0031","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11926-015-0540-1","article-title":"Clinical risk factors for the development of psoriatic arthritis among patients with psoriasis: a review of available evidence","volume":"17","author":"Ogdie","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152639_bib0032","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/art.1780380619","article-title":"The role of HLA antigens as indicators of disease progression in psoriatic arthritis. multivariate relative risk model","volume":"38","author":"Gladman","year":"1995","journal-title":"Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T14:52:09Z","timestamp":1741099929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017225000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":32,"alternative-id":["S0049017225000101"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152639","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of disease outcomes: Early vs. late transition from psoriasis to psoriatic arthritis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152639","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152639"}}